BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 2173409)

  • 1. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study.
    Leoncini L; Del Vecchio MT; Kraft R; Megha T; Barbini P; Cevenini G; Poggi S; Pileri S; Tosi P; Cottier H
    Am J Pathol; 1990 Nov; 137(5):1047-57. PubMed ID: 2173409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
    Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J
    Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD30-positive, anaplastic large-cell lymphomas that express CD15 but lack CD45. A possible diagnostic pitfall.
    Perkins PL; Ross CW; Schnitzer B
    Arch Pathol Lab Med; 1992 Nov; 116(11):1192-6. PubMed ID: 1359849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell (CD30+) lymphomas.
    Carbone A; Gloghini A; Volpe R
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(6):527-32. PubMed ID: 1376944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
    Khalidi HS; Singleton TP; Weiss SW
    Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30/Ki-1-positive anaplastic large cell lymphoma preceded by Hodgkin's disease.
    Tsurumi H; Takahashi T; Moriwaki H; Muto Y
    Int J Hematol; 1992 Aug; 56(1):99-102. PubMed ID: 1327272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas.
    Carbone A; Gloghini A; Volpe R
    Cancer; 1992 Dec; 70(11):2691-8. PubMed ID: 1330287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distinction of Hodgkin's disease from anaplastic large cell lymphoma.
    Frizzera G
    Semin Diagn Pathol; 1992 Nov; 9(4):291-6. PubMed ID: 1480851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease.
    Vermeer MH; Dukers DF; ten Berge RL; Bloemena E; Wu L; Vos W; de Vries E; Tensen CP; Meijer CJ; Willemze R
    Mod Pathol; 2002 Aug; 15(8):838-44. PubMed ID: 12181269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunohistochemistry of Hodgkin's disease.
    Said JW
    Semin Diagn Pathol; 1992 Nov; 9(4):265-71. PubMed ID: 1362283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
    Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
    Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of fascin expression in anaplastic large cell lymphoma and Hodgkin disease.
    Fan G; Kotylo P; Neiman RS; Braziel RM
    Am J Clin Pathol; 2003 Feb; 119(2):199-204. PubMed ID: 12579989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease.
    Bai MC; Jiwa NM; Horstman A; Vos W; Kluin PH; Van der Valk P; Mullink H; Walboomers JM; Meijer CJ
    J Pathol; 1994 Sep; 174(1):49-55. PubMed ID: 7525910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large B-cell lymphoma with Hodgkin's features.
    García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA
    Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine needle aspiration biopsy of Ki-1-positive large-cell "anaplastic" lymphoma.
    Yazdi HM; Burns BF
    Acta Cytol; 1991; 35(3):306-10. PubMed ID: 1645922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotype of Reed-Sternberg and Hodgkin's cells in sequential biopsy specimens of Hodgkin's disease: a paraffin-section immunohistochemical study using the heat-induced epitope retrieval method.
    Vasef MA; Alsabeh R; Medeiros LJ; Weiss LM
    Am J Clin Pathol; 1997 Jul; 108(1):54-9. PubMed ID: 9208978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human macrophages can express the Hodgkin's cell-associated antigen Ki-1 (CD30).
    Andreesen R; Brugger W; Löhr GW; Bross KJ
    Am J Pathol; 1989 Jan; 134(1):187-92. PubMed ID: 2536522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin disease with subsequent transformation to CD30 positive non-hodgkin lymphoma in six patients.
    Mori N; Watanabe K; Yamashita Y; Nakayama A; Yatabe Y; Narita M; Kobayashi T; Hasegawa Y; Kojima H; Nagasawa T
    Cancer; 1999 Feb; 85(4):970-9. PubMed ID: 10091777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.